Codexis (CDXS) Net Equity Issued and Repurchased (2010 - 2025)
Codexis' (CDXS) quarterly Net Equity Issued and Repurchased came in at -$1000.0 in Q4 2025, little changed year-on-year from -$1000.0 in Q4 2024, and little changed quarter-over-quarter from -$1000.0 in Q4 2024.
Codexis (CDXS) Net Equity Issued and Repurchased (2010 - 2025) Analysis & Trends
Codexis' Net Equity Issued and Repurchased history runs 8 years deep, the most recent figure standing at -$1000.0 for Q4 2025.
- On a quarterly basis, Net Equity Issued and Repurchased changed 0.0% year-over-year to -$1000.0 in Q4 2025; TTM through Dec 2025 was $31.3 million, a 0.0% change from a year earlier, with the FY2025 full-year figure at $17.3 million, down 44.87% from the prior year.
- Net Equity Issued and Repurchased steadied at -$1000.0 in Q4 2025 per CDXS's latest filing, from -$1000.0 in the prior quarter.
- Across five years, Net Equity Issued and Repurchased topped out at $31.3 million in Q3 2024 and bottomed at -$1000.0 in Q4 2024.
- The 3-year median for Net Equity Issued and Repurchased is $1.5 million (2023), against an average of $8.0 million.
- Biggest YoY gain for Net Equity Issued and Repurchased was 0.0% in 2025; the steepest drop was 0.0% in 2025.
- Year by year, Net Equity Issued and Repurchased stood at $7.1 million in 2023, then plunged by 100.01% to -$1000.0 in 2024, then changed by 0.0% to -$1000.0 in 2025.
- Per Business Quant, the three latest CDXS Net Equity Issued and Repurchased figures stand at -$1000.0 (Q4 2025), -$1000.0 (Q4 2024), and $31.3 million (Q3 2024).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 163.10 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 141.90 Mn |
| 10 | Codexis | 180.63 Mn | 115.49 Mn | 13.18 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1,000.00 |
| Dec 31, 2025 | -1,000.00 |
| Dec 31, 2024 | -1,000.00 |
| Dec 31, 2024 | -1,000.00 |
| Sep 30, 2024 | 31.32 Mn |
| Sep 30, 2024 | 31.32 Mn |
| Jun 30, 2023 | 7.11 Mn |
| Jun 30, 2023 | 7.11 Mn |
| Mar 31, 2023 | 1.54 Mn |
| Mar 31, 2023 | 1.54 Mn |
| Dec 31, 2019 | -50.00 Mn |
| Dec 31, 2019 | -50.00 Mn |
| Jun 30, 2019 | 49.90 Mn |
| Jun 30, 2019 | 49.90 Mn |
| Dec 31, 2018 | 37.50 Mn |
| Dec 31, 2018 | 37.50 Mn |
| Dec 31, 2017 | 553,000.00 |
| Dec 31, 2017 | 553,000.00 |
| Sep 30, 2017 | -62,000.00 |
| Sep 30, 2017 | -62,000.00 |